Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin plus emotion recognition training for autism spectrum disorder
ACTRN12609000784213Phase 2Recruiting
- Sponsor
- University of New South Wales
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in Autism Spectrum Disorder (ASD) comparing Oxytocin + emotion recognition training with Placebo + emotion recognition training (2 arms). Primary endpoint: Eye gaze to human eyes of computer faces and primary caregiver. Started Sep 2009; status: recruiting.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ACTRN12609000784213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000784213.